The development of neutralizing antibodies in a patient receiving subcutaneous recombinant and natural interleukin-2.

Source:http://linkedlifedata.com/resource/pubmed/id/2004299

Cancer 1991 Apr 1 67 7 1862-4

Download in:

View as

General Info

PMID
2004299